Pfizer Inc (NYSE:PFE)
| 44.06 Delayed Data As of Feb 03 |  -0.285 / -0.64%Today’s Change | 41.45 Today|||52-Week Range 56.32 | -14.02% Year-to-Date |
Latest PFE News | Press Releases
Today’s Trading
| Previous close | 44.34 |
| Today’s open | 44.32 |
| Day’s range | 43.89 - 44.39 |
| Volume | 23,741,990 |
| Average volume (3 months) | 22,056,093 |
| Market cap | $248.9B |
Data as of 4:00pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +41.49% |
| Earnings growth (this year) | -39.60% |
| Earnings growth (next 5 years) | -0.50% |
| Revenue growth (last year) | +23.43% |
| P/E ratio | 8.4 |
| Price/Sales | 2.93 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | +0.07 | +0.05% |
| MRKMerck | -0.00 | -0.00% |
| NVONovo Nordisk | +4.40 | +3.32% |
| AZNAstraZeneca | 0.00 | 0.00% |
Data as of 4:00pm ET, 02/03/2023
Financials
| Next reporting date | May 2, 2023 |
| EPS forecast (this quarter) | $1.02 |
| Annual revenue (last year) | $100.3B |
| Annual profit (last year) | $31.4B |
| Net profit margin | 31.26% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
